Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Cash Flows from Operating Activities:
Net income	$ 9,157	$ 8,999
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for (recovery of) credit losses	329	(758)	$ 1,597
Depreciation	534	547
Net accretion of acquisition accounting adjustments	(685)	(556)
Core deposit intangible amortization	283	330
Net amortization of securities	198	500
Net loss on sale or call of securities available for sale	68	0
Gain on sale of loans held for sale	(144)	(673)
Proceeds from sales of loans held for sale	14,099	26,414
Originations of loans held for sale	(13,544)	(19,784)
Net loss (gain) on sale or disposal of premises and equipment	105	(4)
Equity based compensation expense	437	382
Net change in bank owned life insurance	(161)	(52)
Deferred income tax (benefit) expense	(992)	641
Net change in other assets	2,544	(1,086)
Net change in other liabilities	(2,285)	(34)
Net cash provided by operating activities	9,943	14,866
Cash Flows from Investing Activities:
Proceeds from sales of securities available for sale	13,180	0
Proceeds from maturities, calls and paydowns of securities available for sale	16,794	42,594
Purchases of securities available for sale	0	(67,664)
Net change in restricted stock	3,332	(428)
Net increase in loans	(12,430)	(40,794)
Net change in collateral with other financial institutions	0	1,200
Proceeds from sale of premises and equipment	0	4
Purchases of premises and equipment	(74)	(366)
Net cash provided by (used in) investing activities	20,802	(65,454)
Cash Flows from Financing Activities:
Net change in noninterest-bearing deposits	(48,355)	15,697
Net change in interest-bearing deposits	64,246	20,081
Net change in customer repurchase agreements	62,850	(2,601)
Repayment of other short-term borrowings	(75,531)	0
Common stock dividends paid	(3,191)	(3,006)
Repurchase of common stock	(674)	(3,395)
Proceeds from exercise of stock options	0	12
Net cash (used in) provided by financing activities	(655)	26,788
Net Increase (Decrease) in Cash and Cash Equivalents	30,090	(23,800)
Cash and Cash Equivalents at Beginning of Period	73,340	510,868	510,868
Cash and Cash Equivalents at End of Period	$ 103,430	$ 487,068	$ 73,340